Up-regulation of divalent metal transporter 1 in 6-hydroxydopamine intoxication is IRE/IRP dependent (Q39744987)

14 September 2017

Up-regulation of divalent metal transporter 1 in 6-hydroxydopamine intoxication is IRE/IRP dependent (English)

1 reference

14 September 2017

0 references

0 references

Hong Jiang

1

1 reference

14 September 2017

Ning Song

2

1 reference

14 September 2017

Huamin Xu

3

1 reference

14 September 2017

Shuzhen Zhang

4

1 reference

14 September 2017

Jun Wang

5

1 reference

14 September 2017

Junxia Xie

6

1 reference

14 September 2017

2 February 2010

1 reference

14 September 2017

1 reference

14 September 2017

20

1 reference

14 September 2017

3

1 reference

14 September 2017

345-356

1 reference

https://scigraph.springernature.com/pub.10.1038/cr.2010.20

14 September 2017

0 references

cites work

Iron metabolism in Parkinsonian syndromes

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

Role of iron in neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

Aging and glial responses to lipopolysaccharide in vitro: greater induction of IL-1 and IL-6, but smaller induction of neurotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

Midbrain iron content in early Parkinson disease: a potential biomarker of disease status

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

Time dependent effects of 6-OHDA lesions on iron level and neuronal loss in rat nigrostriatal system

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

Iron, brain ageing and neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

Individual dopaminergic neurons show raised iron levels in Parkinson disease.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

Divalent metal transporter 1 up-regulation is involved in the 6-hydroxydopamine-induced ferrous iron influx

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

Up-regulation of divalent metal transporter 1 is involved in 1-methyl-4-phenylpyridinium (MPP(+))-induced apoptosis in MES23.5 cells

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

An oxidative stress-mediated positive-feedback iron uptake loop in neuronal cells.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

Neurons lacking iron regulatory protein-2 are highly resistant to the toxicity of hemoglobin

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

Iron regulatory proteins increase neuronal vulnerability to hydrogen peroxide

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

Zinc deficiency-induced iron accumulation, a consequence of alterations in iron regulatory protein-binding activity, iron transporters, and iron storage proteins

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

Lack of robust protective effect of quercetin in two types of 6-hydroxydopamine-induced parkinsonian models in rats and dopaminergic cell cultures

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

Leptin protects against 6-hydroxydopamine-induced dopaminergic cell death via mitogen-activated protein kinase signaling

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

Myricetin reduces 6-hydroxydopamine-induced dopamine neuron degeneration in rats.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

Neuroprotective strategies in Parkinson's disease : an update on progress

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

A novel N18TG2 x mesencephalon cell hybrid expresses properties that suggest a dopaminergic cell line of substantia nigra origin

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

Neuroprotective effects of iron chelator Desferal on dopaminergic neurons in the substantia nigra of rats with iron-overload.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

Psychological stress induces dysregulation of iron metabolism in rat brain

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

Iron regulatory proteins are essential for intestinal function and control key iron absorption molecules in the duodenum

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

Upregulation of iron regulatory proteins and divalent metal transporter-1 isoforms in the rat hippocampus after kainate induced neuronal injury

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

Iron/IRP-1-dependent regulation of mRNA expression for transferrin receptor, DMT1 and ferritin during human erythroid differentiation

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

In vitro studies of ferritin iron release and neurotoxicity.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

Inhibition of Biogenic Amine Uptake by Hydrogen Peroxide: A Mechanism for Toxic Effects of 6-Hydroxydopamine

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

Extracellular toxicity of 6-hydroxydopamine on PC12 cells.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

6-hydroxydopamine-induced apoptosis is mediated via extracellular auto-oxidation and caspase 3-dependent activation of protein kinase Cdelta

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

Nitric oxide and oxidative stress (H2O2) control mammalian iron metabolism by different pathways

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

Iron-mediated degradation of IRP2, an unexpected pathway involving a 2-oxoglutarate-dependent oxygenase activity

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

Histochemical distribution of non-haem iron in the human brain

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

Foetal nigral cell suspension grafts influence dopamine release in the non-grafted side in the 6-hydroxydopamine rat model of Parkinson's disease: in vivo voltammetric data

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

Ferroportin1 and hephaestin are involved in the nigral iron accumulation of 6-OHDA-lesioned rats

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

Effects of isatin on rotational behavior and DA levels in caudate putamen in Parkinsonian rats

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

Ghrelin antagonizes MPTP-induced neurotoxicity to the dopaminergic neurons in mouse substantia nigra

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

Iron Acquired from Transferrin by K562 Cells Is Delivered into a Cytoplasmic Pool of Chelatable Iron(II)

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

Role of ascorbic acid in transferrin-independent reduction and uptake of iron by U-937 cells

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

Small-molecule screening identifies the selanazal drug ebselen as a potent inhibitor of DMT1-mediated iron uptake

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

Lack of in vitro protection by a common sunscreen ingredient on UVA-induced cytotoxicity in keratinocytes.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

Structurally dependent redox property of ribonucleotide reductase subunit p53R2.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.20

7 January 2021

Identifiers

DOI

10.1038/CR.2010.20

1 reference

14 September 2017

1 reference